Arterial Occlusive Diseases: Clinical Trials

8,303 trials for Arterial Occlusive Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4372 completed, 1629 unknown, 868 recruiting, 468 terminated. 2992 Not applicable, 927 Phase 4, 662 Phase 2, 630 Phase 3, 320 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2992Completed 1510, Unknown 559, Recruiting 339, Not yet recruiting 179, Terminated 156, Active not recruiting 140, Withdrawn 84, Enrolling by invitation 15, Suspended 10
Phase 4927Completed 507, Unknown 218, Terminated 82, Recruiting 59, Withdrawn 27, Active not recruiting 16, Not yet recruiting 16, Enrolling by invitation 1, Suspended 1
Phase 2662Completed 402, Unknown 128, Terminated 48, Recruiting 38, Withdrawn 22, Not yet recruiting 14, Active not recruiting 8, Suspended 2
Phase 3630Completed 379, Unknown 103, Terminated 66, Recruiting 35, Active not recruiting 22, Not yet recruiting 12, Withdrawn 10, Suspended 2, Enrolling by invitation 1
Phase 1320Completed 205, Unknown 52, Terminated 22, Withdrawn 18, Recruiting 14, Not yet recruiting 7, Active not recruiting 2
Early Phase 149Completed 25, Unknown 8, Recruiting 5, Enrolling by invitation 4, Terminated 3, Not yet recruiting 2, Withdrawn 2

Follow Arterial Occlusive Diseases: new trials by email Literature Review of Arterial Occlusive Diseases trials Research Report on Arterial Occlusive Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease
Not yet recruitingMedical College of Wisconsin602027-12-012026-11-03
Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University802027-11-012026-10-26
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease
Phase 2Not yet recruitingVenturis Therapeutics, Inc.1502027-09-012026-08-19
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
Pegulicianine, Placebo - Carotid Artery Diseases, Peripheral Arterial Disease
Early Phase 1Not yet recruitingMassachusetts General Hospital252027-06-012026-11-10
EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease
Encephaloduroarteriosynangiosis (EDAS), Intensive medical management - Intracranial Atherosclerosis, Intracranial Arterial Stenosis
Not applicableNot yet recruitingCedars-Sinai Medical Center1702027-05-012026-10-22
Heart tEam Decision-making Assisted by Revaz AI Trial
Revaz AI - Coronary Artery Disease
Not applicableNot yet recruitingUniversity of Calgary7122027-04-012026-09-24
OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation
Oral anticoagulation, Single antiplatelet therapy - Atrial Fibrillation (AF), Coronary Artery Disease
Phase 4Not yet recruitingEwha Womans University Mokdong Hospital22027-03-012026-03-27
A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population
transcarotid artery revascularization - Carotid Artery Stenosis
Not yet recruitingBoston Scientific Corporation602027-02-282026-10-30
PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis
Hyperlipidemia, Atherosclerotic Cardiovascular Disease (ASCVD)
Not yet recruitingFundación Santa Fe de Bogota1002027-02-012026-10-02
A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma
Evolocumab, Routine Lipid Management, Autoinjector - Coronary Artery Disease, Hypercholesterolemia
Phase 4Not yet recruitingAmgen3082027-01-312026-09-21
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University302027-01-102026-05-26
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque
Phase 4Not yet recruitingKeqiang Zhao1202027-01-012026-09-15
Nursing Intervention for Adaptation After Myocardial Revascularization
Nursing Intervention Program, Usual Care - Coronary Artery Disease, Myocardial Revascularization
Not applicableNot yet recruitingUniversidad de la Sabana402027-01-012026-05-08
Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting.
Photobiomodulation Therapy, Sham Laser irradiation, Conventional Saphenous Vein Harvesting - Coronary Artery Disease, Coronary Artery Bypass Graft (CABG)
Not applicableNot yet recruitingFederal University of São Paulo2922027-01-012026-10-07
Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment
Lipid-lowering therapy targeting LDL-C <1.0 mmol/L, Lipid-lowering therapy targeting LDL-C 1.0-1.39 mmol/L - Atherosclerotic Cardiovascular Disease (ASCVD)
Not applicableNot yet recruitingBeijing Anzhen Hospital60002027-01-012026-05-29
Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
Intraoperative Ultrasound Blood Flow Measurement - Coronary Artery Disease
Not yet recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1902027-01-012026-08-11
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Arm 1: wCAR-CARE - Precision Prevention (Arm A), Guideline-directed standard of care - Cardiovascular Diseases (CVD), Coronary Artery Disease
Not applicableNot yet recruitingWomen's Heart Austria8002027-01-012026-09-30
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
BOTOX INJECTION - Buerger Disease, Raynaud Syndrome
Phase 3Not yet recruitingUniversity Hospital, Toulouse82027-01-012026-07-23

Showing 20 of 8303. Sign in to see all of them.

Narrower conditions

Coronary Artery Disease (4749)  ·  Atherosclerosis (1489)  ·  Peripheral Arterial Disease (1362)  ·  Cardiovascular Diseases (687)  ·  Myocardial Ischemia (410)  ·  Coronary Disease (407)  ·  Myocardial Infarction (378)  ·  Chronic Limb-Threatening Ischemia (354)  ·  Carotid Stenosis (351)  ·  Diabetes Mellitus (343)  ·  Heart Diseases (333)  ·  Stroke (273)  ·  Acute Coronary Syndrome (264)  ·  Intermittent Claudication (230)  ·  Peripheral Vascular Diseases (224)

Broader conditions

Vascular Diseases (8127)  ·  Cardiovascular Diseases (7616)  ·  Arteriosclerosis (7592)  ·  Heart Diseases (4768)  ·  Myocardial Ischemia (4575)  ·  Coronary Disease (4454)  ·  Pathological Conditions, Signs and Symptoms (2318)  ·  Pathologic Processes (1583)  ·  Atherosclerosis (1481)  ·  Peripheral Vascular Diseases (1415)  ·  Nervous System Diseases (1061)  ·  Central Nervous System Diseases (976)  ·  Brain Diseases (969)  ·  Nutritional and Metabolic Diseases (936)

Interventions

Clopidogrel (226)  ·  Aspirin (193)  ·  Percutaneous Coronary Intervention (160)  ·  Ticagrelor (118)  ·  Atorvastatin (109)  ·  Exercise (87)  ·  Rosuvastatin Calcium (81)  ·  Stents (63)  ·  Prasugrel Hydrochloride (60)  ·  Ezetimibe (59)  ·  Angioplasty (57)  ·  Drug-Eluting Stents (54)  ·  Coronary Artery Bypass (49)  ·  Standard of Care (46)  ·  Simvastatin (42)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (133)  ·  Abbott Medical Devices (99)  ·  Yonsei University (75)  ·  Boston Scientific Corporation (65)  ·  China National Center for Cardiovascular Diseases (61)  ·  Seung-Jung Park (58)  ·  Cordis US Corp. (54)  ·  Seoul National University Hospital (53)  ·  University of Florida (47)  ·  Mayo Clinic (44)  ·  Ottawa Heart Institute Research Corporation (44)  ·  Assiut University (42)  ·  AstraZeneca (41)  ·  Brigham and Women's Hospital (40)  ·  Assistance Publique - Hôpitaux de Paris (39)

Countries

United States (2165)  ·  China (897)  ·  Germany (651)  ·  Italy (487)  ·  South Korea (472)  ·  United Kingdom (466)  ·  France (465)  ·  Netherlands (432)  ·  Canada (417)  ·  Spain (325)  ·  Belgium (316)  ·  Denmark (257)  ·  Switzerland (248)  ·  Austria (222)  ·  Brazil (222)

Top investigators

Seung-Jung Park, MD, PhD (31)  ·  Bon-Kwon Koo, MD, PhD (18)  ·  Marc Bosiers, MD (14)  ·  Koen Deloose, MD (12)  ·  Dominick J Angiolillo, MD, PhD (11)  ·  Gregg W Stone, MD (11)  ·  Ron Waksman, MD (11)  ·  Thomas Zeller, MD (11)  ·  David Kandzari, MD (10)  ·  Mary McDermott, MD (10)  ·  Shao-Liang Chen, MD (10)

Results publications

PMID 42573020, PMID 35224730, PMID 40875095, PMID 42035974, PMID 25940520, PMID 31567024, PMID 24746650, PMID 37565307, PMID 19463432, PMID 20142198, PMID 23468513, PMID 23523454, PMID 23636237, PMID 30165437, PMID 30690141, PMID 31543165, PMID 33025243, PMID 35802393, PMID 36588397, PMID 36645250, PMID 17296825, PMID 23232250, PMID 24510638, PMID 26354543, PMID 26825231, PMID 29089314, PMID 31561250, PMID 32227755, PMID 32609313, PMID 32890442, PMID 33939604, PMID 34056911, PMID 35641327, PMID 35916348, PMID 36137674, PMID 37256598, PMID 37619976, PMID 37745109, PMID 39329200, PMID 40590244, PMID 41913985, PMID 17132052, PMID 17145250, PMID 17223489, PMID 17982182, PMID 18765162, PMID 19228612, PMID 19717846, PMID 20129555, PMID 20484101

NIH funding

2025 (15), 2017 (12), 2023 (11), 2009 (8), 2016 (8), 2018 (8), 2015 (7), 2014 (5), 2019 (5), 2008 (4), U01HL088942 (4), 2005 (3), R01AG031750 (3), R01HL092954 (3), 2004 (2)